Semax in the acute period of hemispheric ischemic stroke
Semax added to intensive therapy was reported to accelerate regression of neurological deficits, especially motor impairment.
What this study tells us
This study compared groups, which is more informative than an uncontrolled report. The amount of confidence still depends on how the groups were formed, how outcomes were measured and how well bias was controlled.
Patients with acute hemispheric ischemic stroke
n=Not stated in search extract
Semax added to intensive therapy was reported to accelerate regression of neurological deficits, especially motor impairment.
Older regional controlled study; methods and endpoints are not described to contemporary trial-reporting standards in the accessible abstract.
Need help with terms such as randomized, placebo, endpoint or sample size? Open the glossary →
Key result
Semax added to intensive therapy was reported to accelerate regression of neurological deficits, especially motor impairment.